Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PHYS vs FNV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FNV Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

FNV Overall Winner 6-Pillar Tally: PHYS 0 – 6 FNV Matrix Metrics: PHYS 3 – 7 FNV

As of Nov 16, 2026, Franco-Nevada Corporation (FNV) is the stronger overall head-to-head candidate over Sprott Physical Gold Trust (PHYS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PHYS carries a Unified Composite Score of 55.5/100 (HOLD) at $29.08 (N/M Forward P/E, 99.9% operating margin), whereas FNV carries 47.8/100 (HOLD) at $240.19 (27.0x Forward P/E, 77.8% operating margin).

  • Composite vs. Pillar Nuance: While PHYS currently prints a higher short-term Unified Composite Score (55.5/100 HOLD vs. FNV 47.8/100 HOLD), FNV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (77.8% vs. 99.9% operating margin) and revenue trajectory (+13.4% vs. N/A YoY).
  • Technical & Structure Timing Caution: PHYS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.1); meanwhile FNV is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PHYS vs FNV
PHYS NYSE Arca
Sprott Physical Gold Trust
Commodity Contracts Brokers & Dealers
$29.08
-0.75% 1D
Market Cap $13.8B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.88β · 27% Vol
Unified Composite Score
55.5 / 100 HOLD
Tech 44.0 Fund 58.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 36
RSI-14: 36.1 · SMA20: $30.30 · SMA50: $31.29
FNV NYSE Head-to-Head Winner
Franco-Nevada Corporation
Gold And Silver Ores
$240.19
-2.76% 1D
Market Cap $47.7B
TTM Revenue $2.37B
Forward P/E 27.0x
Beta / 30D Vol 1.04β · 44% Vol
Unified Composite Score
47.8 / 100 HOLD
Tech 25.0 Fund 49.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.2%) with fading momentum, RSI 47
RSI-14: 47.3 · SMA20: $240.68 · SMA50: $247.20

6-Pillar Scorecard Institutional Category Breakdown (PHYS 0 – 6 FNV)

Columns: Metric · PHYS · FNV
1. Valuation Multiples FNV
Forward P/E N/M 27.0x
Trailing P/E N/M 30.1x
PEG Ratio N/M 11.81x
EV / Revenue N/M 20.1x
2. Growth & Scale FNV
Revenue Growth (YoY) N/A +13.4%
Earnings Growth (YoY) N/A +37.6%
TTM Revenue (USD) N/A $2.37B
Market Cap $13.8B $47.7B
3. Profitability & Quality FNV
Gross Margin N/A 92.5%
Operating Margin 99.9% 77.8%
Net Profit Margin N/A 67.0%
Return on Equity (ROE) N/A 20.1%
4. Balance Sheet & Cash Flow FNV
Cash Generation (TTM) -$62M $1.13B
Cash Flow Margin N/A 47.8%
Net Cash / Leverage N/A ROE $45.61 Book/Sh · 20.1% ROE
Dividend Yield None (0.00%) 0.69%
5. Options & Positioning FNV
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 16.7% (50th %ile) 39.1% (32nd %ile)
Put/Call OI Skew N/A 1.35x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat FNV
OpEx & R&D Intensity N/A 14.7% of Rev ($348M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Commodity Contracts Brokers & Dealers Operator Gold Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PHYS (3) vs FNV (7)
Institutional Metric PHYS FNV Criterion Row Edge
Market Capitalization
Scale
$13.8B $47.7B Larger Scale FNV
Trailing P/E Ratio
Valuation
N/M 30.1x Lower Multiple FNV
Forward P/E Ratio
Valuation
N/M 27.0x Lower Multiple FNV
Revenue Growth (YoY)
Growth
N/A +13.4% Higher Growth FNV
Operating Margin (TTM)
Profitability
99.9% 77.8% Higher Margin PHYS
Net Profit Margin
Profitability
N/A 67.0% Higher Margin FNV
Return on Equity (ROE)
Capital Efficiency
N/A 20.1% Higher ROE FNV
52-Week Range Position
Momentum
1% ($29–$42) 53% ($188–$286) Stronger Trend FNV
Beta / 30D Volatility
Risk Regime
0.88β · 27% Vol 1.04β · 44% Vol Lower Realized Risk PHYS
Unified Institutional Score
Composite Signal
55.5 / 100 (HOLD) 47.8 / 100 (HOLD) Higher Composite PHYS
Trailing 12M Revenue (USD)
Operating Scale
N/A $2.37B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 92.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 11.81x PEG · 20.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$62M (N/A ROE) $1.13B ($45.61 Book/Sh · 20.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FNV +6.23 pp
PHYS: -7.68% · FNV: -1.45%
3M Horizon FNV +15.03 pp
PHYS: -11.93% · FNV: +3.1%
6M Horizon FNV +22.25 pp
PHYS: -15.69% · FNV: +6.56%
1Y Horizon FNV +30.18 pp
PHYS: -8.29% · FNV: +21.89%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period PHYS Revenue FNV Revenue PHYS Op. Margin FNV Op. Margin Margin Leader
Q3 '25 $8.02B $1.95B 99.9% 69.1% PHYS
Q4 '25 $6.72B $2.39B 99.8% 76.6% PHYS
Q1 '26 $5.25B $2.60B 99.9% 88.3% PHYS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PHYS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 16.7%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PHYS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FNV CONSOLIDATION
58d in phase · OBV NEUTRAL
Current IV 39.1%
IV Percentile 32nd %ile
Put/Call OI Skew 1.35x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FNV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PHYS Moat Profile High-Margin Pricing Power Moat
Commodity Contracts Brokers & Dealers Operator
Competes within the Commodity Contracts Brokers & Dealers value chain with $13.8B market capitalization and 99.9% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
FNV Moat Profile High-Margin Pricing Power Moat
Gold Operator
Competes within the Gold value chain with $47.7B market capitalization and 77.8% operating margin.
OpEx & R&D Reinvestment 14.7% of Rev ($348M)
90D Engineering Disclosures 0 Published

Investor FAQ PHYS vs FNV Key Questions & Quantitative Answers

As of Nov 16, 2026, Franco-Nevada Corporation (FNV) is the stronger overall head-to-head candidate over Sprott Physical Gold Trust (PHYS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PHYS carries a Unified Composite Score of 55.5/100 (HOLD) at $29.08 (N/M Forward P/E, 99.9% operating margin), whereas FNV carries 47.8/100 (HOLD) at $240.19 (27.0x Forward P/E, 77.8% operating margin). Composite vs. Pillar Nuance: While PHYS currently prints a higher short-term Unified Composite Score (55.5/100 HOLD vs. FNV 47.8/100 HOLD), FNV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (77.8% vs. 99.9% operating margin) and revenue trajectory (+13.4% vs. N/A YoY). Technical & Structure Timing Caution: PHYS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.1); meanwhile FNV is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FNV leads the Growth & Scale pillar: PHYS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, 99.9% operating margin), compared with FNV at +13.4% YoY revenue growth and +37.6% YoY earnings growth on $2.37B TTM revenue (92.5% gross margin, 77.8% operating margin). Across the 3-period historical trajectory (Q3 '25 to Q1 '26), PHYS cumulative revenue shifted -34.5% while FNV shifted +33.3%. In operating R&D and SG&A reinvestment, PHYS deploys N/A (0 90-day corporate R&D disclosures) versus 14.7% of Rev ($348M) (0 disclosures) for FNV.

FNV screens cheaper on headline valuation multiples. PHYS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas FNV trades at 27.0x Forward P/E, 30.1x Trailing P/E, 11.81x PEG, and 20.1x EV/Revenue (47.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PHYS (N/A ROE) versus FNV (20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, PHYS carries 16.7% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.88β · 27% Vol realized risk). By comparison, FNV carries 39.1% implied volatility (32nd %ile, Balanced (25th–60th %ile)), a 1.35x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.04β · 44% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.